1. Midnolin is a confirmed genetic risk factor for Parkinson's disease. Issue 11 (6th October 2019) Authors: Obara, Yutaro; Sato, Hidenori; Nakayama, Takahiro; Kato, Takeo; Ishii, Kuniaki Journal: Annals of clinical and translational neurology Issue: Volume 6:Issue 11(2019) Page Start: 2205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reply to: MIDN locus structural variants and Parkinson's disease risk. Issue 4 (22nd March 2020) Authors: Obara, Yutaro; Sato, Hidenori; Nakayama, Takahiro; Kato, Takeo; Ishii, Kuniaki Journal: Annals of clinical and translational neurology Issue: Volume 7:Issue 4(2020) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗